Cargando…
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
There is an urgent need to repurpose drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent computational-experimental screenings have identified several existing drugs that could serve as effective inhibitors of the virus’ main protease, M(pro), which is involved in gene...
Autores principales: | Menéndez, Cintia A., Byléhn, Fabian, Perez-Lemus, Gustavo R., Alvarado, Walter, de Pablo, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486088/ https://www.ncbi.nlm.nih.gov/pubmed/32917717 http://dx.doi.org/10.1126/sciadv.abd0345 |
Ejemplares similares
-
Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors
por: Perez-Lemus, Gustavo R., et al.
Publicado: (2022) -
Modeling the Binding Mechanism of Remdesivir, Favilavir,
and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase
por: Byléhn, Fabian, et al.
Publicado: (2021) -
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021) -
Electrochemical Biosensor for the Detection of SARS-CoV-2 Main Protease and Its Inhibitor Ebselen
por: Zhang, Qiongyu, et al.
Publicado: (2022) -
Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease
por: Thun‐Hohenstein, Siegfried T. D., et al.
Publicado: (2021)